Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

Presentations Access:

clear all | select all

Presentation Access:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Plenary Session 2: Targeting the PI3K Pathway

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Plenary Session 2: Targeting the PI3K Pathway
Targeting the PI3K pathway in cancer
Dr. William R. Sellers
Novartis Institutes for BioMedical Research, Cambridge, MA
from 2009 Molecular Targets and Cancer Therapeutics conference on November 16, 2009 2:30 PM-4:30 PM
Plenary Session 2: Targeting the PI3K Pathway
Growth control by the mTOR pathway
Dr. David M. Sabatini
MIT Whitehead Institute for Biomedical Research, Cambridge, MA
from 2009 Molecular Targets and Cancer Therapeutics conference on November 16, 2009 2:30 PM-4:30 PM
Plenary Session 2: Targeting the PI3K Pathway
Targeting PI3K in Breast Cancer
Dr. Jean J. Zhao
Dana-Farber Cancer Institute, Boston, MA
from 2009 Molecular Targets and Cancer Therapeutics conference on November 16, 2009 2:30 PM-4:30 PM
Plenary Session 2: Targeting the PI3K Pathway
Finding biomarkers of resistance to EGFR targeted therapy in cancer
Dr. René Bernards
The Netherlands Cancer Institute, Amsterdam, The Netherlands
from 2009 Molecular Targets and Cancer Therapeutics conference on November 16, 2009 2:30 PM-4:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4